Since only immature tumor vessels are VEGF-dependent for survival [21] and tumor vessels resistant to anti-angiogenic treatments display pericyte coverage [22], a high maturation index of vessels in BM may account for the insensitivity to these drugs. The gene discussed is VEGFA; the disease is neoplasm.